Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,006 public trials 571 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

Ph 1b Study to Evaluate GSK2110183 in Combination With Bortezomib and Dexamethasone in Subjects With Multiple Myeloma

NCT01428492

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Novartis Investigative Site Scottsdale, Arizona, United States
  • Novartis Investigative Site Duarte, California, United States
  • Novartis Investigative Site Atlanta, Georgia, United States
  • Novartis Investigative Site Chicago, Illinois, United States
View all 13 locations
View Trial Details
Completed

Carfilzomib + High Dose Melphalan as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation

NCT01690143

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • UAB Birmingham, Alabama, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Medical University of South Carolina Hollings Cancer Center Charleston, South Carolina, United States
  • Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Completed

Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone in Elderly Myeloma Patients

NCT00232934

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease, +15 more
Locations
  • Divisionedi Ematologia - Ospedali Riuniti Bergamo, Italy
  • Istituto di Ematologia e Oncologia Medica "Seragnoli"- Università di Bologna Bologna, Italy
  • Divisione di Ematologia - Az. Osp. S.Croce Carle Cuneo, Italy
  • U.O. di Ematologia e Trapianto di Cellule Staminali, IRCCS Casa Sollievo della Sofferenza Foggia, Italy
View all 13 locations
View Trial Details
Completed

Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors

NCT02071888

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Winship Cancer Institute of Emory School of Medicine Atlanta, Georgia, United States
  • John Theruer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details
Completed

Ilaris® Effects in Schnitzler Syndrome (ILESCH)

NCT01390350

Conditions
Immune System Diseases, Immunoproliferative Disorders, Monoclonal Gammopathy of Undetermined Significance, +2 more
Locations
  • Allergie-Centrum-Charité, Charité University Berlin, Germany
  • Dept. of Dermatology, Klinikum Darmstadt Darmstadt, Germany
  • Dept. of Dermatology, University Heidelberg Heidelberg, Germany
  • Dept. of Dermatology, University Münster Münster, Germany
View Trial Details

Related conditions